Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunities
Science Advances · 08.05.2026 · 12 (19)
DOI: 10.1126/sciadv.aec7001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 08.05.2026. Verfasst von Yu Seong Ham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Life Science, Hanyang University, Ansan-si, Gyeonggi-do 15588, South Korea. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Signal Transduction, Bacterial Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Increasing antibiotic-resistant bacterial infections pose a global public health challenge that demands therapeutic strategies beyond conventional antibiotics. The cyclic guanosine monophosphate–adenosine monophosphate synthase stimulator of interferon genes (cGAS-STING) pathway is crucial to innate immune defense through cytosolic DNA detection and antimicrobial response initiation. Emerging evidence suggests that antibiotic-resistant bacteria can subvert or overactivate this pathway, leading to immune evasion and excessive inflammation. Methicillin-resistant Staphylococcus aureus , carbapenem-resistant Acinetobacter baumannii , and multidrug-resistant Mycobacterium tuberculosis exploit cGAS-STING signaling to suppress host immunity or trigger damaging hyperinflammatory responses. This highlights the dual nature of the cGAS-STING pathway in bacterial infections. STING agonists may enhance immune responses against persistent infections, and STING inhibitors can mitigate excessive inflammation caused by resistant pathogens. Targeting the cGAS-STING pathway represents a host-directed therapy that modulates host immunity rather than targeting pathogens. Understanding the interplay between cGAS-STING signaling and antibiotic resistance mechanisms is essential for developing next-generation immunotherapeutics to complement conventional antibacterial treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Life Science, Hanyang University, Ansan-si, Gyeonggi-do 15588, South Korea.
- Department of Molecular Medicine, School of Biopharmaceutical Convergence, Ansan-si, Gyeonggi-do 15588, South Korea.
- Biopeptics Inc., Ansan-si, Gyeonggi-do 15588, South Korea.
ORCID-Profile: Yu Seong Ham, Minseo Jeong, Chul-Su Yang
Förderung
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Ham, Y. S., Jeong, M., & Yang, C. S. (2026). Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunities. Science Advances, 12(19). https://doi.org/10.1126/sciadv.aec7001
Vancouver
Ham YS, Jeong M, Yang CS. Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunities. Science Advances. 2026;12(19). doi:10.1126/sciadv.aec7001
BibTeX
@article{Ham2026,
author = {Ham, Yu Seong and Jeong, Minseo and Yang, Chul-Su},
title = {Targeting cGAS-STING signaling to overcome antibiotic-resistant bacterial infections: Challenges and opportunities},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {19},
doi = {10.1126/sciadv.aec7001}
}
EUVIMED